Agile Therapeutics Inc. (NASDAQ: AGRX) Attends 31st Annual ROTH Conference
Agile Therapeutics (NASDAQ: AGRX) is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. The company’s product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Agile’s lead product candidate, Twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. Twirla is based on Agile’s proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. About NetworkNewsWire…







